InvestorsHub Logo

chickpea598

06/22/17 10:56 AM

#39493 RE: dr_lowenstein #39492

Anticipation of data by year end should have us back around $2. Good news will likely lead to FDA approval and a product heading to market. That is reality and the market will reward that.